Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayo-Yusuf, O A
Right arrow Articles by Pickworth, W B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayo-Yusuf, O A
Right arrow Articles by Pickworth, W B
Tobacco Control 2004;13:186-189
© 2004 BMJ Publishing Group Ltd


RESEARCH PAPER

Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa

O A Ayo-Yusuf1, T J P Swart2, W B Pickworth3

1 Department of Community Dentistry, University of Pretoria, South Africa
2 Department of Oral Pathology and Oral Biology, University of Pretoria, South Africa
3 National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, USA

Correspondence to:
O Ayo-Yusuf
MPH, Department of Community Dentistry, Oral and Dental Hospital, University of Pretoria, PO Box 1266, Pretoria 0001, South Africa; lekan.ayoyusuf{at}up.ac.za

Objectives: Smokeless tobacco (SLT) use is popular among black South African women and children. The study sought to determine the nicotine delivery capability of popular industrialised and traditional SLT brands in South Africa, and to provide information for policy action by regulatory authorities.

Design: Laboratory chemical analysis of four industrialised and one traditional SLT products commercially available, using previously published analytical methods. Potential for dependence was inferred from nicotine delivery capabilities determined by the percentage free base nicotine.

Measurements: Moisture, pH, total nicotine, and percentage free base nicotine.

Results: Total nicotine content was between 6–16 mg/g. The pH varied between 7–10 and this correlated with percentage free base nicotine, which ranged between 10–99%. The nicotine delivery capability of the traditional product was lower than that of the industrialised products except for the recently introduced portion bag snus, which had comparable total nicotine but the lowest pH and percentage free base nicotine. The most popular SLT brands showed the highest percentage free base nicotine ever reported for any industrialised SLT or cigarette brands. Small cans contained higher nicotine than the large cans of the same brand tested. Findings from the study support a potential for limited "product graduation" by users.

Conclusions: South African SLT users are mostly exposed to potentially very highly addictive levels of nicotine that may favour tobacco dependence and its consequent health risks. The increasing use of SLT by women of childbearing age support the need for intensified policy action to control its use.


Keywords: free base; nicotine; smokeless tobacco; South Africa; women




This article has been cited by other articles:


Home page
Tobacco ControlHome page
O A Ayo-Yusuf, P S Reddy, and B W van den Borne
Association of snuff use with chronic bronchitis among South African women: implications for tobacco harm reduction
Tob. Control, April 1, 2008; 17(2): 99 - 104.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, and P Boyle
Toward a comprehensive long term nicotine policy
Tob. Control, June 1, 2005; 14(3): 161 - 165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.